Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 ...

It was the first in a series of drugs that are, for the first time, effective against obesity and can help lessen the moral ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to ...

People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food.

Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, during a session on India Today Conclave 2025, said that many celebrities may not want to admit to taking Ozempic ...

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

Persica's antibiotic-based drug could benefit patients with chronic lower back pain who are suffering from an infection in ...

The Department of Health has said it is continuing to take "decisive action" against the illegal promotion, supply or misuse ...

Vikrant Shrotriya, Novo Nordisk India's Managing Director, addressed concerns over the side-effects of Ozempic. He said that the weight-loss drug has been through a thorough evaluation process.